Cargando…

In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer

Background: Breast cancer is the most common type of cancer worldwide. Cyclin-dependent kinase inhibition is one of the backbones of metastatic breast cancer therapy. However, there are a significant number of therapy failures. This study evaluates the biomarker potential of microRNAs for the predic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asberger, Jasmin, Berner, Kai, Bicker, Anna, Metz, Marius, Jäger, Markus, Weiß, Daniela, Kreutz, Clemens, Juhasz-Böss, Ingolf, Mayer, Sebastian, Ge, Isabell, Erbes, Thalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604872/ https://www.ncbi.nlm.nih.gov/pubmed/37893081 http://dx.doi.org/10.3390/biomedicines11102705

Ejemplares similares

Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study
por: Berner, Kai, et al.
Publicado: (2021)

Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
por: Klauser, Anna-Lena, et al.
Publicado: (2021)

Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteins
por: Asberger, Jasmin, et al.
Publicado: (2020)

Prognostic value and management of regional lymph nodes in locoregional breast cancer recurrence: a systematic review of the literature
por: Ge, Isabell, et al.
Publicado: (2022)

Treatment of Cesarean Scar and Cervical Pregnancies Using the Ovum Aspiration Set for Intrachorial Methotrexate Injection as a Conservative, Fertility-Preserving Procedure
por: Ge, Isabell, et al.
Publicado: (2023)

Circulating non-coding RNA-biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
por: Ritter, Andrea, et al.
Publicado: (2019)

[(68)Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer
por: Michalski, Kerstin, et al.
Publicado: (2023)

Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker
por: Erbes, Thalia, et al.
Publicado: (2015)

Expression of Prostate Specific Membrane Antigen (PSMA) in Breast Cancer
por: Unger, Clara, et al.
Publicado: (2022)

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer
por: Stoian, Raluca, et al.
Publicado: (2023)

Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis
por: Wolf, Jule, et al.
Publicado: (2022)

Status of Sentinel Lymph Node Biopsy in Vulvar and Cervical Cancer
por: Waldschmidt, Julia, et al.
Publicado: (2020)

Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform
por: Schaal, Kathrin, et al.
Publicado: (2015)

microRNAs: tiny regulators of synapse function in development and disease
por: Bicker, Silvia, et al.
Publicado: (2008)

Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis
por: Stoian, Raluca, et al.
Publicado: (2021)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

The Importance of Extended Analysis Using Current Molecular Genetic Methods Based on the Example of a Cohort of 228 Patients with Hereditary Breast and Ovarian Cancer Syndrome
por: Resch, Luise D., et al.
Publicado: (2021)

Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
por: Müller, Carolin, et al.
Publicado: (2021)

Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients
por: Müller, Carolin, et al.
Publicado: (2020)

MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2
por: Moradimotlagh, Atieh, et al.
Publicado: (2019)

MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment
por: Andrikopoulou, Angeliki, et al.
Publicado: (2021)

Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis
por: Huss, Alexandra, et al.
Publicado: (2022)

Exometabolom analysis of breast cancer cell lines: Metabolic signature
por: Willmann, Lucas, et al.
Publicado: (2015)

MicroRNA-138 controls hippocampal interneuron function and short-term memory in mice
por: Daswani, Reetu, et al.
Publicado: (2022)

MicroRNA-191 triggers keratinocytes senescence by SATB1 and CDK6 downregulation
por: Lena, A.M., et al.
Publicado: (2012)

MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8
por: Li, MingHua, et al.
Publicado: (2015)

Status of Sentinel Lymph Node Biopsy in Endometrial Cancer
por: Taran, Florin Andrei, et al.
Publicado: (2021)

MicroRNA-188 suppresses G(1)/S transition by targeting multiple cyclin/CDK complexes
por: Wu, Jiangbin, et al.
Publicado: (2014)

MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
por: Zhang, Jun-feng, et al.
Publicado: (2018)

Phenotypical microRNA screen reveals a noncanonical role of CDK2 in regulating neutrophil migration
por: Hsu, Alan Y., et al.
Publicado: (2019)

Molecular and in vivo Functions of the CDK8 and CDK19 Kinase Modules
por: Dannappel, Marius Volker, et al.
Publicado: (2019)

MicroRNA-198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK4
por: Kang, Yuanyuan, et al.
Publicado: (2021)

Neurologic Consultations and Headache during Pregnancy and in Puerperium: A Retrospective Chart Review
por: Zimmermann, Julia S. M., et al.
Publicado: (2023)

The interplay of CDK4 and CDK6 in melanoma
por: Kollmann, Karoline, et al.
Publicado: (2019)

Conisation course for medical students-experience from a German University Hospital
por: Takacs, Ferenc Zoltan, et al.
Publicado: (2020)

HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer
por: Hirschfeld, Marc, et al.
Publicado: (2015)

MicroRNA-545 Suppresses Cell Proliferation by Targeting Cyclin D1 and CDK4 in Lung Cancer Cells
por: Du, Bowen, et al.
Publicado: (2014)

MicroRNA-Mediated Suppression of the TGF-β Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance
por: Cornell, Liam, et al.
Publicado: (2019)

MicroRNA-1-Mediated Inhibition of Cardiac Fibroblast Proliferation Through Targeting Cyclin D2 and CDK6
por: Valkov, Nedyalka, et al.
Publicado: (2019)

Tumor-suppressive microRNA-152 inhibits the proliferation of Ewing’s sarcoma cells by targeting CDK5R1
por: Kawano, Masanori, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eevmmgv561679nb3igqn7a26s7